VU0152099
| SMILES | Cc1cc(C)c2c(n1)sc(c2N)C(=O)NCc1ccc2c(c1)OCO2 |
| InChIKey | AZOGCTMOKNTHIU-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 6 |
| Hydrogen bond donors | 2 |
| Rotatable bonds | 3 |
| Molecular weight (Da) | 355.1 |
Drug properties
| Molecular type | Small molecule |
| Endogenous/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| RXFP4 | RL3R2 | Human | Relaxin family peptide | A | pKi | 8.81 | 8.91 | 8.83 | Guide to Pharmacology |
| RXFP1 | RXFP1 | Human | Relaxin family peptide | A | pKi | 7.5 | 7.75 | 8.0 | Guide to Pharmacology |
| RXFP2 | RXFP2 | Human | Relaxin family peptide | A | pKi | 7.0 | 7.0 | 7.0 | Guide to Pharmacology |
| RXFP3 | RL3R1 | Human | Relaxin family peptide | A | pKi | 7.78 | 8.35 | 8.92 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| RXFP4 | RL3R2 | Human | Relaxin family peptide | A | pIC50 | 8.8 | 8.9 | 9.0 | Guide to Pharmacology |
| RXFP4 | RL3R2 | Human | Relaxin family peptide | A | pEC50 | 8.7 | 9.2 | 9.7 | Guide to Pharmacology |
| RXFP3 | RL3R1 | Human | Relaxin family peptide | A | pIC50 | 9.4 | 9.5 | 9.6 | Guide to Pharmacology |
| RXFP3 | RL3R1 | Human | Relaxin family peptide | A | pEC50 | 8.26 | 9.1 | 9.93 | Guide to Pharmacology |